Zyvox, Linezolid News

LONDON, UK , 23 May 2012 - It is hoped that an increase in serious hospital-acquired infections such as MRSA will be combatted by the new and improved drug treatment options in the pipeline due for launch in the near future, according to pharmaceutical experts GlobalData.

HAYWARD, Calif. and SHANGHAI, April 23, 2012 /PRNewswire/ -- MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, today announced the completion of its Phase 1 clinical trial for MRX-I, its first development-stage antibiotic drug candidate.

Drugmaker Pfizer Inc. has agreed to pay Oregon more than $3.3 million to settle claims that the company used misleading statements and studies to market an antibiotic.

Oregon Attorney General John Kroger announced Tuesday a $3.34 million agreement with the world's largest research-based pharmaceutical company, Pfizer, Inc., over allegedly deceptive marketing claims related to its prescription drug Zyvox.